IMC Chicago’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229M Sell
935,400
-181,700
-16% -$42.3M 0.08% 161
2025
Q4
$231M Buy
1,117,100
+189,400
+20% +$37.5M 0.08% 146
2025
Q3
$172M Buy
927,700
+150,400
+19% +$25.8M 0.06% 178
2025
Q2
$119M Buy
777,300
+199,200
+34% +$30.6M 0.05% 199
2025
Q1
$95.9M Buy
578,100
+140,000
+32% +$21.9M 0.05% 190
2024
Q4
$63.4M Sell
438,100
-67,000
-13% -$10.4M 0.03% 289
2024
Q3
$81.9M Buy
505,100
+14,900
+3% +$2.37M 0.04% 212
2024
Q2
$71.6M Buy
490,200
+84,100
+21% +$12.5M 0.04% 218
2024
Q1
$64.2M Buy
406,100
+27,200
+7% +$4.33M 0.04% 204
2023
Q4
$59.4M Sell
378,900
-34,000
-8% -$5.21M 0.04% 220
2023
Q3
$64.3M Buy
412,900
+12,800
+3% +$2.11M 0.06% 160
2023
Q2
$66.2M Buy
400,100
+95,900
+32% +$15.5M 0.06% 146
2023
Q1
$47.2M Sell
304,200
-126,900
-29% -$20.5M 0.06% 184
2022
Q4
$76.2M Buy
431,100
+197,900
+85% +$34.2M 0.12% 94
2022
Q3
$38.1M Buy
233,200
+2,100
+0.9% +$355K 0.05% 173
2022
Q2
$41M Buy
231,100
+41,200
+22% +$7.34M 0.06% 164
2022
Q1
$33.7M Sell
189,900
-125,800
-40% -$21.4M 0.03% 243
2021
Q4
$54M Sell
315,700
-105,700
-25% -$17.3M 0.04% 191
2021
Q3
$68.1M Buy
421,400
+122,500
+41% +$20.9M 0.07% 133
2021
Q2
$49.2M Buy
298,900
+99,400
+50% +$16.5M 0.06% 169
2021
Q1
$32.8M Buy
199,500
+6,800
+4% +$1.1M 0.05% 199
2020
Q4
$30.3M Buy
192,700
+45,500
+31% +$6.71M 0.04% 198
2020
Q3
$21.9M Buy
147,200
+6,000
+4% +$888K 0.03% 189
2020
Q2
$19.9M Sell
141,200
-14,000
-9% -$2.04M 0.04% 157
2020
Q1
$20.4M Buy
155,200
+71,000
+84% +$10.1M 0.04% 143
2019
Q4
$12.3M Buy
84,200
+2,400
+3% +$326K 0.03% 186
2019
Q3
$10.6M Sell
81,800
-65,900
-45% -$8.68M 0.03% 171
2019
Q2
$20.6M Sell
147,700
-61,600
-29% -$8.53M 0.07% 98
2019
Q1
$29.3M Buy
209,300
+46,700
+29% +$6.26M 0.11% 54
2018
Q4
$21M Buy
+162,600
New +$22.7M 0.06% 66

Other funds holding JNJ

IMC Chicago's JNJ Position: Q1 2026 in Review

IMC Chicago sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 69,404 shares — an estimated $16.2M sold.

IMC Chicago first reported a position in JNJ in Q4 2019 and held it in 5 quarters. The position peaked at $14.4M in Q4 2025. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • IMC Chicago reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 69,404 Johnson & Johnson shares in Q1 2026, an estimated $16.2M.
  • IMC Chicago first reported a position in Johnson & Johnson in Q4 2019 and held it in 5 quarters.
  • IMC Chicago's Johnson & Johnson position peaked at $14.4M in Q4 2025.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.